ESR1 c.352T>G ;(p.S118A)

Variant ID: 6-152129399-T-G

NM_000125.3(ESR1):c.352T>G;(p.S118A)

This variant was identified in 8 publications

View GRCh38 version.




Publications:


Endocrine Resistance in Breast Cancer: The Role of Estrogen Receptor Stability.

Cells
Jeffreys, Sarah A SA; Powter, Branka B; Balakrishnar, Bavanthi B; Mok, Kelly K; Soon, Patsy P; Franken, André A; Neubauer, Hans H; de Souza, Paul P; Becker, Therese M TM
Publication Date: 2020-09-11

Variant appearance in text: ESR1: S118A
PubMed Link: 32932819
Variant Present in the following documents:
  • Main text
  • cells-09-02077.pdf
View BVdb publication page



Notch Signaling Pathway and Endocrine Resistance in Breast Cancer.

Frontiers In Pharmacology
Bai, Jing-Wen JW; Wei, Min M; Li, Ji-Wei JW; Zhang, Guo-Jun GJ
Publication Date: 2020

Variant appearance in text: ESR1: S118A
PubMed Link: 32636747
Variant Present in the following documents:
  • Main text
  • fphar-11-00924.pdf
View BVdb publication page



The estrogen receptor-alpha S118P variant does not affect breast cancer incidence or response to endocrine therapies.

Breast Cancer Research And Treatment
Button, Berry B; Croessmann, Sarah S; Chu, David D; Rosen, D Marc DM; Zabransky, Daniel J DJ; Dalton, W Brian WB; Cravero, Karen K; Kyker-Snowman, Kelly K; Waters, Ian I; Karthikeyan, Swathi S; Christenson, Eric S ES; Donaldson, Josh J; Hunter, Tasha T; Dennison, Lauren L; Ramin, Cody C; May, Betty B; Roden, Richard R; Petry, Dana D; Armstrong, Deborah K DK; Visvanathan, Kala K; Park, Ben Ho BH
Publication Date: 2019-04

Variant appearance in text: ESR1: S118A
PubMed Link: 30560461
Variant Present in the following documents:
  • Main text
View BVdb publication page



Feedback control of the CXCR7/CXCL11 chemokine axis by estrogen receptor α in ovarian cancer.

Molecular Oncology
Benhadjeba, Samira S; Edjekouane, Lydia L; Sauvé, Karine K; Carmona, Euridice E; Tremblay, André A
Publication Date: 2018-10

Variant appearance in text: ESR1: S118A
PubMed Link: 30051594
Variant Present in the following documents:
  • Main text
  • MOL2-12-1689.pdf
  • MOL2-12-1689-s001.pdf
View BVdb publication page



ERpS294 is a biomarker of ligand or mutational ERα activation and a breast cancer target for CDK2 inhibition.

Oncotarget
Scott, Gary K GK; Chu, David D; Kaur, Ravneet R; Malato, Julia J; Rothschild, Daniel E DE; Frazier, Katya K; Eppenberger-Castori, Serenella S; Hann, Byron B; Park, Ben Ho BH; Benz, Christopher C CC
Publication Date: 2017-10-13

Variant appearance in text: ESR1: S118A
PubMed Link: 29137354
Variant Present in the following documents:
  • Main text
  • oncotarget-08-83432.pdf
View BVdb publication page



Endometrial cancer-associated mutants of SPOP are defective in regulating estrogen receptor-α protein turnover.

Cell Death & Disease
Zhang, P P; Gao, K K; Jin, X X; Ma, J J; Peng, J J; Wumaier, R R; Tang, Y Y; Zhang, Y Y; An, J J; Yan, Q Q; Dong, Y Y; Huang, H H; Yu, L L; Wang, C C
Publication Date: 2015-03-12

Variant appearance in text: ESR1: S118A
PubMed Link: 25766326
Variant Present in the following documents:
  • Main text
  • cddis201547a.pdf
View BVdb publication page



BRCA1 regulates acetylation and ubiquitination of estrogen receptor-alpha.

Molecular Endocrinology (Baltimore, Md.)
Ma, Yongxian Y; Fan, Saijun S; Hu, Changyan C; Meng, Qinghui Q; Fuqua, Suzanne A SA; Pestell, Richard G RG; Tomita, York A YA; Rosen, Eliot M EM
Publication Date: 2010-01

Variant appearance in text: ER-alpha: S118A
PubMed Link: 19887647
Variant Present in the following documents:
  • Main text
View BVdb publication page



Formation of an hER alpha-COUP-TFI complex enhances hER alpha AF-1 through Ser118 phosphorylation by MAPK.

The Embo Journal
Métivier, Raphaël R; Gay, Frédérique A FA; Hübner, Michael R MR; Flouriot, Gilles G; Salbert, Gilles G; Gannon, Frank F; Kah, Olivier O; Pakdel, Farzad F
Publication Date: 2002-07-01

Variant appearance in text: NR3A1: S118A
PubMed Link: 12093745
Variant Present in the following documents:
  • Main text
View BVdb publication page